Home
  >  
Section 13
  >  
Chapter 12,822

Standardization of an experimental murine model of invasive pulmonary aspergillosis

Sheppard, D.C.; Graybill, J.R.; Najvar, L.K.; Chiang, L.Y.; Doedt, T.; Kirkpatrick, W.R.; Bocanegra, R.; Vallor, A.C.; Patterson, T.F.; Filler, S.G.

Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503

2006

ISSN/ISBN: 0066-4804
PMID: 17005844
DOI: 10.1128/aac.00787-06
Accession: 012821445
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Evaluating new therapeutic agents for invasive aspergillosis requires animal models that are reproducible among different laboratories. We therefore evaluated a murine model of aerosol infection in two independent laboratories and found a high level of both intra- and interlaboratory reproducibility of survival, fungal burden over time, and the efficacy of liposomal amphotericin B.

Full Text Article emailed within 0-6 h: $19.90




Related References

Eisenstein, D.J.; Biddinger, P.W.; Rhodes, J.C. 1990: Experimental murine invasive pulmonary aspergillosis American Journal of Clinical Pathology 93(4): 510-515
Sheppard, D.C.; Rieg, G.; Chiang, L.Y.; Filler, S.G.; Edwards, J.E.; Ibrahim, A.S. 2004: Novel inhalational murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911
Clemons, K.V.; Schwartz, J.A.; Stevens, D.A. 2011: Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis Medical Mycology 49(8): 834-847
Chiang, L.Y.; Ejzykowicz, D.E.; Tian, Z.-Q.; Katz, L.; Filler, S.G. 2006: Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466
Szigeti, Z.M.; Talas, L.; Palicz, Z.; Szentesi, P.; Hargitai, Z.; Csernoch, L.; Balla, J.; Pocsi, I.; Banfalvi, G.; Szeman-Nagy, G. 2018: Murine model to follow hyphal development in invasive pulmonary aspergillosis Applied Microbiology and Biotechnology 102(6): 2817-2825
Grahl, N.; Kowalski, C.H.; Cramer, R.A. 2021: Detection of Low Oxygen Microenvironments in a Murine Model of Invasive Pulmonary Aspergillosis Using Pimonidazole Methods in Molecular Biology 2260: 197-205
Bhattacharya, S.; Amarsaikhan, N.; Maupin, A.J.; Schlosser, A.; Füchtbauer, E.-M.; Holmskov, U.; Moeller, J.B.; Templeton, S.P. 2021: FIBCD1 Deficiency Decreases Disease Severity in a Murine Model of Invasive Pulmonary Aspergillosis Immunohorizons 5(12): 983-993
Mondon, P.; De Champs, C.; Donadille, A.; Ambroise-Thomas, P.; Grillot, R. 1996: Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis Journal of Medical Microbiology 45(3): 186-191
Madan, T.; Kishore, U.; Singh, M.; Strong, P.; Hussain, E.M.; Reid, K.B.; Sarma, P.U. 2001: Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis Infection and Immunity 69(4): 2728-2731
Kaur, S.; Gupta, V.K.; Thiel, S.; Sarma, P.U.; Madan, T. 2007: Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis Clinical and Experimental Immunology 148(2): 382-389
Nawada, R.; Amitani, R.; Tanaka, E.; Niimi, A.; Suzuki, K.; Murayama, T.; Kuze, F. 1996: Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection Journal of Clinical Microbiology 34(6): 1433-1439
Wiederhold, N.P.; Kontoyiannis, D.P.; Chi, J.; Prince, R.A.; Tam, V.H.; Lewis, R.E. 2004: Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity Journal of Infectious Diseases 190(8): 1464-1471
Peng, Y.; Zhang, H.; Xu, M.; Tan, M-Wah. 2018: A Tet-Off gene expression system for validation of antifungal drug targets in a murine invasive pulmonary aspergillosis model Scientific Reports 8(1): 443
Hartigan, A.J.; Westwick, J.; Jarai, G.; Hogaboam, C.M. 2009: CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis Journal of Immunology 183(8): 5171-5179
Wiederhold,N.P.; Najvar,L.K.; Vallor,A.C.; Kirkpatrick,W.R.; Bocanegra,R.; Molina,D.; Olivo,M.; Graybill,J.R.; Patterson,T.F. 2008: Assessment of serum - beta -D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis Antimicrobial Agents And Chemotherapy: 3, 1176-1178
Wiederhold, N.P.; Najvar, L.K.; Vallor, A.C.; Kirkpatrick, W.R.; Bocanegra, R.; Molina, D.; Olivo, M.; Graybill, J.R.; Patterson, T.F. 2008: Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 52(3): 1176-1178
Lewis, R.E.; Prince, R.A.; Chi, J.; Kontoyiannis, D.P. 2002: Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis Antimicrobial Agents and Chemotherapy 46(10): 3208-3214
Lewis, R.E.; Albert, N.D.; Kontoyiannis, D.P. 2008: Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 52(11): 4178-4180
Wiederhold, N.P.; Tam, V.H.; Chi, J.; Prince, R.A.; Kontoyiannis, D.P.; Lewis, R.E. 2006: Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 50(2): 469-473
Hummel, M.; Baust, C.; Kretschmar, M.; Nichterlein, T.; Schleiermacher, D.; Spiess, B.; Skladny, H.; Mörz, H.; Hehlmann, Rüdiger.; Buchheidt, D. 2004: Detection of Aspergillus DNA by a nested PCR assay is superior to blood culture in an experimental murine model of invasive aspergillosis Journal of Medical Microbiology 53(Pt 8): 803-806